Higher rates of miscarriage could be caused by oral antifungal drug
Published in CMAJ, new research has found that oral antifungal drug used to treat yeast infections is linked to higher rates of miscarriage.
A commonly...
Eye damage: can heavy smoking impair vision?
Researchers have taken a closer look into eye damage, by understanding the detrimental effects of what chronic smoking can have on spatial and colour...
Have researchers found a new approach to treating aggressive cancer?
Researchers at MD Anderson, USA, discovered some forms of aggressive cancer may respond to a combination of immunotherapy and DNA damage repair inhibitors.
According to...
Home flooring toxins found and children carry the evidence
Presented at the American Association for the Advancement of Science, researchers found children to carry evidence of harmful substances from furniture and home flooring...
Artificially sweetened beverages could cause stroke in post-menopausal women
Among post-menopausal women, drinking multiple artificially sweetened beverages daily was associated with an increase in the risk of having a stroke.
According to research published...
New research indicates that physiological age is better at predicting death
Published in the European Journal of Preventive Cardiology, research says predicting death does not necessarily come down to how old you are, it comes...
Could advanced software reduce arrhythmia heart disease?
Potentially lethal conditions such as arrhythmia heart disease may become easier to identify thanks to innovative new software that measures electrical activity in the...
Human papilloma virus: shaming women could put off cancer screening
The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, and potentially deter them from getting cervical screening.
According to...
Which strategies are most likely to slow down Parkinson’s disease?
Experts explore which of the existing strategies to slow down or stop the processes of Parkinson’s disease are most likely to be successful over...
What do you know about immune checkpoint inhibitors?
Immune checkpoint inhibitors have become important tools for managing non-small-cell lung cancer (NSCLC), could the analysis identify individuals with malignant diseases?
Reported in The Journal...
Could new diagnostic procedures differentiate between cancer & inflammation?
Published in the American Journal of Pathology, new diagnostic procedures reveal a protein biomarker that accurately differentiates bladder cancer from benign inflammation.
A report in...
Gut microbiota: 2,000 unknown bacteria discovered in the human gut
EMBL's European Bioinformatics Institute and the Wellcome Sanger have discovered almost 2,000 bacterial species living in the human gut microbiota, many of which were...
Did you know that women are less likely to receive geriatric care?
More than 70% of patients receiving surgery for hip fracture are women, yet they are less likely than men to receive geriatric care during...
Small cell lung cancer: the world of highly lethal cancers
Researchers from Weill Cornell Medicine studied highly lethal cancers, using human embryonic stem cells to create a new model system specifically exploring small cell...
Crippling effects of Aspergillus fumigatus on the human immune system
According to University of Jena, Germany, a toxic substance from the fungus Aspergillus fumigatus, can threaten the lives of people with a compromised immune...
Do you think AI could treat Chronic Obstructive Pulmonary Disease?
According to WHO, Chronic Obstructive Pulmonary Disease will be the third leading cause of death worldwide by 2030, but could AI successfully treat this?
Following...
Obesity related cancer: surgeon warns rise amongst millennials
A while back Health Europa reported on obesity related cancer to be on the rise, particularly in the US, but now Britain’s millennials may...
Worrying multidrug resistance in remote Arctic soil microbes
Potentially having ominous implications for human health worldwide, scientists have discovered an unsettling multidrug resistance in distant Arctic soil microbes.
Published in Environment International, a...
Presenting Lymphit: The tech designed to benefit cancer survivors
Dicronis introduces Lymphit – a cutting-edge technology that will disrupt traditional lymphoedema diagnosis methods for the benefit of cancer survivors.
Patrizia Marschalkova, CEO of Dicronis...
A combination of treatments may help fight breast cancer
According to researchers from the University of Helsinki, Finland, cancer cells can be attacked with a ‘drug cocktail’ which can potentially help to fight...
